Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...
The work with Nvidia also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in lab ...
B.C.’s globally competitive biotech sector is pushing forward with more UBC-spin-off companies that harness both research and ...
The industry contributes $50 billion to the state GDP, and employs 130,000 people across research and manufacturing.
A biotechnology startup is harnessing the unique space environment to manufacture artificial retinas that could one day ...
Dr. Jessica Maloh to lead Continuing Medical Education session 'The Biology of Breakouts”; Codex Labs to feature its plant-biotech acne portfolio and Decode.Me integrative dermatology platform ...
Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...
A medicinal chemist at a biotech company decided to take matters into his own hands after a coworker escalated a simple labeling mistake to management. What could have been a minor error turned into a ...
GEA has moved its Application and Technology Center (ATC) for New Food and biotechnology from Hildesheim to Sarstedt in Lower Saxony, Germany, investing €4 ...
This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...
Preview this article 1 min Regulators on Tuesday approved a proposed blood cancer treatment from Orca Bio, a company with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results